请输入邮箱和密码进行绑定操作：

XtalPi scores landmark deal for AI drug discovery

交易方DoveTree的创立者是哈佛大学终身教授Gregory Verdine，他是化学生物学领域的权威学者，曾提出“drug the undruggable”（靶向“不可成药”靶点）理念。

Molly Wen

更新于2025年8月18日 20:08 Molly Wen

For Chinese drug research firms, 2025 is shaping up as the year of the mega deal.

Several drug discovery companies have signed licensing agreements with eye-popping headline figures for their promising prototypes that, if clinically successful, could be worth billions of dollars to the developers.

读者评论

用户名

密码

咏竹坊

咏竹坊（官网链接）提供在香港和美国上市的中国企业相关新闻，重点关注中小企业和筹备上市的公司。

Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.